69 results
8-K
ZOM
Zomedica Corp
5 Jan 21
Departure of Directors or Certain Officers
4:15pm
year. Mr. Cohen will be eligible to receive an annual discretionary bonus of up to $200,000 each fiscal year based on the achievement of certain … performance and financial objectives for such fiscal year established by the Board. Pursuant to the employment agreement, Mr. Cohen’s bonus for fiscal year
8-K
EX-10.1
ZOM
Zomedica Corp
5 Jan 21
Departure of Directors or Certain Officers
4:15pm
with the Corporation's standard payroll practice for executive officers.
5.2 Cash Bonus. The Executive shall be eligible to earn an annual … discretionary cash bonus (the “Cash Bonus”), in a target amount equal to TWO HUNDRED THOUSAND UNITED STATES DOLLARS (US$200,000). The amount of the Cash Bonus
8-K
EX-10.1
ZOM
Zomedica Corp
23 Dec 20
Departure of Directors or Certain Officers
5:11pm
with the Corporation's compensation policy.
- 3 -
Quarterly Cash Bonus. The Executive shall be eligible to earn a quarterly cash bonus (the "Quarterly Bonus … "). Such Quarterly Bonus will be calculated upon the achievement of performance objectives that will be established by the Board (as recommended
8-K
EX-10.2
ZOM
Zomedica Corp
23 Dec 20
Departure of Directors or Certain Officers
5:11pm
and may be increased in accordance with the Corporation's compensation policy.
Quarterly Cash Bonus. The Executive shall be eligible to earn a quarterly … cash bonus (the "Quarterly Bonus"). Such Quarterly Bonus will be calculated upon the achievement of performance objectives that will be established
8-K
EX-10.1
ZOM
Zomedica Corp
4 Oct 21
Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan
6:15am
with the Corporation's standard payroll practice for executive officers.
5.2 Cash Bonus. The Executive shall be eligible to earn an annual discretionary … cash bonus (the “Cash Bonus”), in a target amount equal to TWO HUNDRED THOUSAND UNITED STATES DOLLARS (US$200,000). The amount of the Cash Bonus
8-K
bfmiuv 7qzq13us
23 Dec 20
Departure of Directors or Certain Officers
5:11pm
8-K
EX-10.30
2r2u57h9
17 Sep 19
Zomedica names Dr. Stephanie Morley President
4:01pm
8-K
EX-99.1
nhi khpyulhor1d47md
8 Aug 19
Zomedica Announces Second Quarter 2019 Financial Results
4:16pm
8-K/A
EX-10.1
0e720d mwf5owsoj
1 Jul 20
Departure of Directors or Certain Officers
4:01pm
8-K
EX-99.1
7g4vllhj7ilwohx31l8e
13 Nov 18
Zomedica Pharmaceuticals Corp. Announces Third Quarter 2018 Financial Results
4:53pm
8-K
EX-99.1
uemxm8om
26 Feb 19
Zomedica Pharmaceuticals Corp. Announces Year End 2018 Financial Results
4:13pm
8-K
EX-99.2
c6b91tvr cka
19 Jan 21
Other Events
4:30pm
8-K
EX-10.1
afcey575w2myh5c48sp
17 Jun 20
Departure of Directors or Certain Officers
4:46pm
8-K
EX-99.1
qv85nm5r
26 Feb 21
Zomedica Corp. Announces Year End 2020 Financial Results
4:20pm
8-K
EX-99.1
p8kxiobflzx jd
10 May 19
Zomedica Announces First Quarter 2019 Financial Results
5:28pm
8-K
EX-10.1
zutf41g
17 May 21
Zomedica Hires Vice President Business Development to Lead Acquisition and Licensing Efforts
6:15am
8-K
ql75l 0geqr
15 Jun 22
Departure of Directors or Certain Officers
4:16pm